| dc.contributor.author | Ethiopian Food and Drug Authority | |
| dc.date.accessioned | 2026-02-24T08:48:38Z | |
| dc.date.available | 2026-02-24T08:48:38Z | |
| dc.date.issued | 2025 | |
| dc.identifier.uri | http://repository.iphce.org/xmlui/handle/123456789/5351 | |
| dc.description.abstract | The Ethiopian Food and Drug Authority (EFDA) is committed to safeguarding public health by ensuring the safety, efficacy, and quality of medicines circulating in the Ethiopian market. In alignment with its legal mandate as stipulated under Proclamation No. 1112/2019 and the Pharmacovigilance Directive No. 932/2022, EFDA continues to strengthen its regulatory oversight through robust pharmacovigilance systems and procedures. | en_US |
| dc.language.iso | en_US | en_US |
| dc.subject | Pharmacovilgilance | en_US |
| dc.title | Guideline to conduct good pharmacovigilance practice inspection | en_US |
| dc.type | Guideline | en_US |